PGIM India Healthcare Fund Regular G
Summary Info
Fund Name
: PGIM India Mutual Fund
Scheme Name
: PGIM India Healthcare Fund Regular G
AMC
: PGIM India Mutual Fund
Type
: Open
Category
: Equity - Pharma
Launch Date
: 19-Nov-2024
Fund Manager
: Anandha Padmanabhan Anjen
Net Assets (Rs. cr)
: 106.92
PGIM India Healthcare Fund Regular G - Nav Details
Nav Date
: 10-Dec-2025
NAV [Rs.]
: 9.85
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
: For Exits within 90 days from date of allotment of units: 0.50% For Exits beyond 90 days from date of allotment of units: NIL
PGIM India Healthcare Fund Regular G- NAV Chart
PGIM India Healthcare Fund Regular G- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | -1.4 | -1.79 | -0.4 | 0.81 | -1.5 | - | - | -1.48 |
| Category Avg | -1.63 | -1.5 | -1.6 | 1.24 | -1.52 | 22.35 | 16.18 | 13.93 |
| Category Best | -1.34 | -0.46 | 0.6 | 5.89 | 5.27 | 27.79 | 19.04 | 29.71 |
| Category Worst | -2.65 | -3.14 | -3.48 | -3.57 | -8.41 | 18.45 | 12.07 | -5.69 |
PGIM India Healthcare Fund Regular G- Latest Dividends
No Records Found
PGIM India Healthcare Fund Regular G- Investment Details
Min. Investment(Rs.)
: 5000
Increm.Investment(Rs.)
: 1000
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
Zydus Lifesci.5,256
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 11.72 | 63808 | 11.68 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 9.97 | 15349 | 9.94 |
| Equity | Max Healthcare | Healthcare Services | 7.21 | 61801 | 7.18 |
| Equity | Aster DM Health. | Healthcare Services | 6.23 | 93349 | 6.21 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 6.01 | 47601 | 5.99 |
| Equity | J B Chemicals & | Pharmaceuticals & Biotechnology | 5.11 | 28785 | 5.09 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 4.65 | 20595 | 4.63 |
| Equity | Rubicon Research | Pharmaceuticals & Biotechnology | 4.29 | 65290 | 4.28 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 3.92 | 15260 | 3.90 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 3.61 | 1198 | 3.60 |
| Equity | Krishna Institu. | Healthcare Services | 3.46 | 50377 | 3.45 |
| Equity | PB Fintech. | Financial Technology (Fintech) | 2.89 | 15822 | 2.87 |
| Equity | Dr Lal Pathlabs | Healthcare Services | 2.86 | 9345 | 2.85 |
| Equity | Navin Fluo.Intl. | Chemicals & Petrochemicals | 2.82 | 4909 | 2.81 |
| Equity | Neuland Labs. | Pharmaceuticals & Biotechnology | 2.73 | 1574 | 2.72 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 2.52 | 6760 | 2.51 |
| Equity | Global Health | Healthcare Services | 2.41 | 19251 | 2.39 |
| Equity | Sai Life | Pharmaceuticals & Biotechnology | 2.37 | 26736 | 2.36 |
| Equity | Jupiter Life Lin | Healthcare Services | 2.30 | 15520 | 2.29 |
| Equity | ICICI Lombard | Insurance | 1.84 | 9318 | 1.83 |
| Equity | Anthem Bioscienc | Pharmaceuticals & Biotechnology | 1.75 | 27457 | 1.74 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 1.75 | 11372 | 1.74 |
| Equity | Sagility | IT - Services | 1.28 | 254284 | 1.27 |
| Equity | Rainbow Child. | Healthcare Services | 1.16 | 8555 | 1.15 |
| Equity | Lenskart Solut. | Retailing | 1.03 | 24971 | 1.02 |
| Equity | Orchid Pharma | Pharmaceuticals & Biotechnology | 0.86 | 10285 | 0.85 |
| Equity | Dr Agarwal's Eye | Healthcare Services | 0.54 | 933 | 0.53 |
| Equity | Dr Agarwal's Hea | Healthcare Services | 0.51 | 9500 | 0.50 |
| Equity | Blue Jet Health | Pharmaceuticals & Biotechnology | 0.27 | 4657 | 0.26 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
PGIM India Mutual Fund
Incorporation Date:
24-Sep-2008
Total Assets Managed (Cr.):
26,927.05
Trustee/s:
Rakesh Sood, PGIM India Trustees Priva, Mr. Vijay Agarwal, Mr. Sujal Shah, Mr. John Praveen, Mr. Ashwini Kakkar
Chairman:
NA
CEO / MD:
Ajit Menon, Abhishek Tiwari
CIO:
NA
President:
NA
Director/s:
Mr.Muralidharan Rajamani, Glenwyn Peter Baptist, Kapil Wadhawan, Mr.David Wan Chang, Mr.Indrasena Yala Reddy, Dr. V. R. Narasimham
Compliance Officer/s:
Mr. Sandeep Kamath, Mr. Sumesh Kumar
Investor Service Officer/s:
Murali Ramasubramanian
Fund Manager/s:
Anandha Padmanabhan Anjen
Auditors:
Price Waterhouse Chartere
OTHER INFORMATION
Registered Office:
4th Floor, C Wing, Laxmi Towers, Bandra Kurla Complex, Bandra (East), Mumbai - 400 051
Contact Nos:
022-61593000
Fax:
022-61593100
Email:
Website:
